trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ruh MF et al. The effects of histone acetylation on estrogen responsiveness in MCF-7 cells. 1999 Endocrine pmid:10709763
Yoshida M and Horinouchi S Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. 1999 Ann. N. Y. Acad. Sci. pmid:10667200
Sowa Y et al. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. 1999 Ann. N. Y. Acad. Sci. pmid:10667218
Kim YB et al. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. 1999 Ann. N. Y. Acad. Sci. pmid:10667219
Condreay JP et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9874783
Cameron EE et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. 1999 Nat. Genet. pmid:9916800
Yoshida M [Discovery of cell cycle inhibitors and their application to molecular biology]. 1999 Jpn J Antibiot pmid:10221182
Feng YQ et al. Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells. 1999 Mol. Cell. Biol. pmid:10373540
Böger H and Gruss P Functional determinants for the tetracycline-dependent transactivator tTA in transgenic mouse embryos. 1999 Mech. Dev. pmid:10381574
Ghosh AK et al. MBP-1 physically associates with histone deacetylase for transcriptional repression. 1999 Biochem. Biophys. Res. Commun. pmid:10403782
Gradin K et al. Repression of dioxin signal transduction in fibroblasts. Identification Of a putative repressor associated with Arnt. 1999 J. Biol. Chem. pmid:10224119
Kim YB et al. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. 1999 Oncogene pmid:10229197
Johnson BS et al. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. 1999 Mol. Cell. Biol. pmid:10207061
Niki T et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. 1999 Hepatology pmid:10051490
Hasegawa T et al. Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter. 1999 Biochem. Biophys. Res. Commun. pmid:10066455
Inokoshi J et al. Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. 1999 Biochem. Biophys. Res. Commun. pmid:10079191
Olsson TG et al. Transient inhibition of histone deacetylase activity overcomes silencing in the mating-type region in fission yeast. 1999 Curr. Genet. pmid:10079326
Collas P et al. Active transgenes in zebrafish are enriched in acetylated histone H4 and dynamically associate with RNA Pol II and splicing complexes. 1999 J. Cell. Sci. pmid:10198286
Saito A et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10200307
Bordonaro M et al. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. 1999 Cell Growth Differ. pmid:10547075
KraevskiÄ­ VA and Prasolov VS [Comparative analysis of higher levels of organization of normal and hyperacetylated chromatin]. 1999 Dokl. Akad. Nauk. pmid:10439916
Zabel MD et al. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. 1999 J. Immunol. pmid:10453011
Bernhard D et al. Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line. 1999 Cell Death Differ. pmid:10453071
Liu Z et al. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10449719
Wang J et al. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. 1999 Cancer Res. pmid:10383127
Suzuki T et al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. 1999 J. Med. Chem. pmid:10425110
Tagami T et al. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. 1999 J. Biol. Chem. pmid:10428804
Radkov SA et al. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. 1999 J. Virol. pmid:10364319
Croft JA et al. Differences in the localization and morphology of chromosomes in the human nucleus. 1999 J. Cell Biol. pmid:10366586
Criqui-Filipe P et al. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. 1999 EMBO J. pmid:10369679
Zhao W et al. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. 1999 J. Virol. pmid:10233965
Lin RJ et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. 1998 Nature pmid:9486654
Grignani F et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. 1998 Nature pmid:9486655
Wong J et al. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. 1998 EMBO J. pmid:9430643
Magnaghi-Jaulin L et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. 1998 Nature pmid:9468140
Svensson K et al. The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. 1998 Development pmid:9389664
El Kharroubi A et al. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. 1998 Mol. Cell. Biol. pmid:9566873
Gray SG and Ekström TJ Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. 1998 Biochem. Biophys. Res. Commun. pmid:9571167
Nan X et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. 1998 Nature pmid:9620804
Kim YB et al. phd1+, a histone deacetylase gene of Schizosaccharomyces pombe, is required for the meiotic cell cycle and resistance to trichostatin A. 1998 FEBS Lett. pmid:9781677
Egawa K et al. Identification of active substances from Streptomyces culture fluids using p53-independent expression of p21/WAF1/Cip1 gene and their mode of action. 1998 Biol. Pharm. Bull. pmid:9781835
Kohge T et al. Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation. 1998 Biochem. Pharmacol. pmid:9825735
Hu JF et al. The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene. 1998 Biochem. Biophys. Res. Commun. pmid:9792787
Korhonen P et al. Expression of transcriptional repressor protein mSin3A but not mSin3B is induced during neuronal apoptosis. 1998 Biochem. Biophys. Res. Commun. pmid:9813182
Waterborg JH Dynamics of histone acetylation in Chlamydomonas reinhardtii. 1998 J. Biol. Chem. pmid:9765294
Madisen L et al. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes. 1998 Mol. Cell. Biol. pmid:9774645
Eden S et al. DNA methylation models histone acetylation. 1998 Nature pmid:9732866
Phelan MW et al. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. 1998 J. Lab. Clin. Med. pmid:9851743
Ciana P et al. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. 1998 EMBO J. pmid:9857194
De Luca P et al. Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription. 1998 J. Cell. Biochem. pmid:9671233